PineBridge Investments L.P. boosted its position in Safeguard Scientifics Inc. (NYSE:SFE) by 50.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,591 shares of the company’s stock after buying an additional 2,880 shares during the period. PineBridge Investments L.P.’s holdings in Safeguard Scientifics were worth $107,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. LaSalle Street Capital Management LLC raised its stake in shares of Safeguard Scientifics by 2.5% in the second quarter. LaSalle Street Capital Management LLC now owns 11,714 shares of the company’s stock worth $146,000 after buying an additional 287 shares during the last quarter. Foundry Partners LLC raised its stake in shares of Safeguard Scientifics by 0.3% in the second quarter. Foundry Partners LLC now owns 166,794 shares of the company’s stock worth $2,083,000 after buying an additional 475 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Safeguard Scientifics by 0.8% in the second quarter. JPMorgan Chase & Co. now owns 87,552 shares of the company’s stock worth $1,094,000 after buying an additional 664 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Safeguard Scientifics by 2.9% in the second quarter. Bank of New York Mellon Corp now owns 85,765 shares of the company’s stock worth $1,071,000 after buying an additional 2,448 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Safeguard Scientifics by 0.9% in the first quarter. State Street Corp now owns 343,847 shares of the company’s stock worth $4,559,000 after buying an additional 3,217 shares during the last quarter. Hedge funds and other institutional investors own 78.62% of the company’s stock.
Shares of Safeguard Scientifics Inc. (NYSE:SFE) opened at 13.39 on Friday. Safeguard Scientifics Inc. has a 1-year low of $11.40 and a 1-year high of $18.07. The company has a 50-day moving average price of $13.51 and a 200-day moving average price of $13.32. The company’s market cap is $270.80 million.
Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, July 28th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.47 by $0.45. During the same period in the previous year, the firm posted ($0.91) EPS. Equities research analysts expect that Safeguard Scientifics Inc. will post $0.24 earnings per share for the current fiscal year.
Separately, Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research report on Thursday, June 30th.
In other Safeguard Scientifics news, CEO Stephen T. Zarrilli purchased 3,900 shares of the company’s stock in a transaction that occurred on Wednesday, September 14th. The shares were acquired at an average cost of $12.75 per share, for a total transaction of $49,725.00. Following the completion of the acquisition, the chief executive officer now owns 103,606 shares of the company’s stock, valued at approximately $1,320,976.50. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.67% of the company’s stock.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).
Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics Inc. (NYSE:SFE).
Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.